See also this year's filing and all EDGAR filings for this company.
PDF Report 0001581720_2018_Loxo_Oncology_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001581720, Loxo Oncology Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 781,807,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 912,000 |
| 3 | remainder_Assets | 723,000 |
| 4 | LiabilitiesCurrent | 221,570,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 183,662,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 33,657,000 |
| 9 | ResearchAndDevelopmentExpense | 140,039,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 24,820,000 |
| 13 | remainder_ComprehensiveNetIncome | -551,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 783,442,000 |
| 1 | Liabilities | 405,232,000 |
| 2 | Expenses | 173,696,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 378,210,000 |
| 5 | NetIncome | -148,876,000 |
| 6 | ComprehensiveNetIncome | -149,151,500 |
| 7 | BaseVar | 693,870,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.14 |
| 9 | EconomicCapitalRatio | 2.41 |
Edgar->Model Mapping
Feature Distribution
